Skip to content Skip to footer
Subscribe Now
Viewpoints_Dipal Doshi
VIEWPOINTS

PharmaShots Interview: Entrada’s Dipal Doshi Shares Insights on the Series B Funding Utilize to Advance DMD Program into the Clinic

In an interview with PharmaShots, Dipal Doshi, President and Chief Executive Officer of Entrada Therapeutics share his views on $116M Series B financing and what does this milestone means for the company's pipeline. Shots: The Series B financing was led by Wellington Management Company, who was joined by Redmile Group, TCG Crossover, Greenspring Associates, Point72, Qatar Investment…
May 19, 2021

Read more

Viewpoints_Andrew Spiegel
VIEWPOINTS

PharmaShots Interview: GCCA’s Andrew Spiegel Shares Insights on the Clear Your View Campaign

In an interview with PharmaShots, Andrew Spiegel, Executive Director of the Global Colon Cancer Association shares the details of the campaign and put colors on the impact of complete biomarker testing for advanced CRC patients. Shots: The Clear Your View campaign is an awareness initiative sponsored by Guardant Health to raise awareness of the importance of complete biomarker testing…
May 18, 2021

Read more

Viewpoints_Sneha Nair and Claire Crossett
VIEWPOINTS

PharmaShots Interview: Women First Digital’s Sneha Nair and Claire Crossett Share Insights on the Launch of World’s First Abortion Virtual Assistant, Ally on WhatsApp

In an interview with PharmaShots, Sneha Nair, Global Communications Officer and Claire Crossett, Assistant Director at Women First Digital share insight on the launch of the world's first-ever abortion virtual assistant, Ally, on WhatsApp in celebration of World Health Day's 2021 theme: Building a fairer, healthier world. Shots: Ally, the HowToUse chatbot, is equipped to answer all medical abortion-related…
May 17, 2021

Read more

Viewpoints_Gilles Cottier
VIEWPOINTS

PharmaShots Interview: Aceto’s Gilles Cottier Shares Insight on the Acquisition of A&C and IsleChem

In an interview with PharmaShots, Gilles Cottier, Chief Executive Officer of Aceto shared his views on the acquisitions of A&C and IsleChem to highlight the company's growth strategy. Shots: The acquisition of IsleChem has allowed the company to expand its manufacturing expertise in the US. Aceto currently has diversified access to a robust global supply chain network The acquisition…
May 11, 2021

Read more

Viewpoints_Dr. Med. Steven Hildemann
VIEWPOINTS

PharmaShots Interview: Ipsen’s Dr. Med. Steven Hildemann Shares Insight on the EC’s Approval of Cabometyx + Nivolumab for Advanced Renal Cell Carcinoma

In an interview with PharmaShots, Prof. Dr. Med. Steven Hildemann, Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs, and Patient Safety of Ipsen share his views on the approval of the combination regimen for aRCC. He also shed light on the company's near-term goals in the coming years. Shots: The EC approval is based…
May 11, 2021

Read more

Viewpoints_Thierry Abribat
VIEWPOINTS

PharmaShots Interview: Amolyt Pharma’s Thierry Abribat Shares Insight on AZP-3601 for Hypoparathyroidism

In an interview with PharmaShots, Thierry Abribat, Founder and Chief Executive Officer of Amolyt Pharma share his views on the clinical profile of AZP-3601. He also shed light on how it differs from other treatments in development for hypoparathyroidism. Shots: Amolyt Pharma presented positive data from the single ascending dose (SAD) portion of its Ph1 study evaluating AZP-3601…
May 10, 2021

Read more

Viewpoints_Sven Sjovall & Dr. Mark Watt
VIEWPOINTS

PharmaShots Interview: J&J’s Sven Sjovall & Dr. Mark Watt Share Insight on Nicorette’s Latest Digital Smoking Cessation Offering

In an interview with PharmaShots, Johnson & Johnson's Sven Sjovall, Sr Director, R&D Site Lead and Global Smoking Cessation, and Dr. Mark Watt, Senior Director Medical Affairs and Clinical Research at Johnson & Johnson share their views on Nicorette's latest digital smoking cessation offering and the science behind the QuickMist SmartTrack. They also shed some light on…
May 5, 2021

Read more

Viewpoints_Dr. Drew Falconer
VIEWPOINTS

PharmaShots Interview: Dr. Drew Falconer Shares Insights on the Abbott’s NeuroSphere Virtual Clinic

In an interview with PharmaShots, Dr. Drew Falconer, Neurologist and Director at Inova Parkinson's and Movement Disorders Center in Fairfax, Va. shares insights on the first neurostimulation technology in the US that allows patients to receive treatment from the doctor without leaving home. Shots: Abbott launches NeuroSphere Virtual Clinic that allows patients to communicate with their physicians,…
May 3, 2021

Read more

Viewpoints_Emmanuel Dulac
VIEWPOINTS

PharmaShots Interview: Zealand Pharma’s Emmanuel Dulac Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult Patients with Diabetes

In an interview with PharmaShots, Emmanuel Dulac, Pharm.D., Ph.D., President and CEO of Zealand Pharma shares insight on the US FDA's approval of Zegalogue and its availability in both an auto-injector and a prefilled syringe in June 2021. He also highlighted the importance of approval for the company and patients with hypoglycemia.   Shots: The approval is based…
April 28, 2021

Read more

Viewpoints_Dr. Lara S. Sullivan and Dr. Ronald Herbst
VIEWPOINTS

PharmaShots Interview: Pyxis Oncology’s Dr. Lara S. Sullivan and Dr. Ronald Herbst Share Insights on the Importance of Series B Funding to Advance their Portfolio

In an interview with PharmaShots, Dr. Lara S. Sullivan, Chief Executive Officer, and Dr. Ronald Herbst, Chief Scientific Officer of Pyxis Oncology share insight on the importance of Series B funding and shed light on the company's strategy and near-term goals. Shots: Pyxis Oncology reported that it raised $152M in a series B on the heels of…
April 26, 2021

Read more

Load more